TOI vs. AGL

In the year-to-date period, TOI achieves a 206.70% return, which is significantly higher than AGL's 87.89% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for The Oncology Institute, Inc. (TOI) and agilon health, inc. (AGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current TOI Sharpe Ratio is -0.46, which is comparable to the AGL Sharpe Ratio of -0.51. The chart below compares the historical Sharpe Ratios of TOI and AGL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither TOI nor AGL has paid dividends to shareholders.

The maximum TOI drawdown since its inception was -98.79%, roughly equal to the maximum AGL drawdown of -96.37%. Use the drawdown chart below to compare losses from any high point for TOI and AGL. For additional features, visit the drawdowns tool.

The Oncology Institute, Inc. (TOI) has a higher volatility of 44.96% compared to agilon health, inc. (AGL) at 20.47%. This indicates that TOI's price experiences larger fluctuations and is considered to be riskier than AGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between The Oncology Institute, Inc. and agilon health, inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.